Table 1.
CEA | CXCL17 | CXCL16 | GPR35 V2/3 | LGR5 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
r | p-Value | r | p-Value | r | p-Value | r | p-Value | r | p-Value | ||
GPR55 | All CRC LNs | −0.08 | 0.123 | −0.04 | 0.421 | 0.33 | <0.0001 | 0.28 | <0.0001 | 0.33 | <0.0001 |
TNM Stage I LNs | 0.21 | 0.075 | 0.43 | 0.0001 | 0.64 | <0.0001 | 0.58 | <0.0001 | 0.56 | <0.0001 | |
TNM Stage II LNs | −0.10 | 0.155 | 0.004 | 0.958 | 0.47 | <0.0001 | 0.42 | <0.0001 | 0.48 | <0.0001 | |
TNM Stage III LNs | −0.18 | 0.098 | −0.24 | 0.027 | 0.17 | 0.120 | 0.15 | 0.150 | 0.21 | 0.047 | |
TNM Stage IV LNs | −0.46 | 0.009 | −0.38 | 0.036 | −0.50 | 0.005 | −0.39 | 0.028 | −0.31 | 0.092 |
The correlation coefficients (r) and the p-values were calculated by two-tailed Spearman’s rank order correlation test. Levels are given as mRNA copies/18S rRNA unit.